Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.2 - $0.48 $119 - $285
595 Added 5.24%
11,953 $2,000
Q2 2024

Aug 12, 2024

SELL
$0.38 - $1.13 $6,618 - $19,682
-17,418 Reduced 60.53%
11,358 $4,000
Q1 2024

May 13, 2024

BUY
$0.88 - $1.2 $13,134 - $17,911
14,926 Added 107.77%
28,776 $29,000
Q4 2023

Feb 13, 2024

BUY
$1.04 - $3.15 $14,404 - $43,627
13,850 New
13,850 $16,000

Others Institutions Holding MYNZ

# of Institutions
1
Shares Held
10.9K
Call Options Held
0
Put Options Held
0

About MAINZ BIOMED N.V.


  • Ticker MYNZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 14,483,000
  • Market Cap $61.1M
  • Description
  • Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...
More about MYNZ
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.